Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
about
Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature reviewTreatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medicationAn open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosisA Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes.No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.
P2860
Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Efficacy and metabolic influenc ...... h 52 weeks follow-up in China.
@en
Efficacy and metabolic influenc ...... h 52 weeks follow-up in China.
@nl
type
label
Efficacy and metabolic influenc ...... h 52 weeks follow-up in China.
@en
Efficacy and metabolic influenc ...... h 52 weeks follow-up in China.
@nl
prefLabel
Efficacy and metabolic influenc ...... h 52 weeks follow-up in China.
@en
Efficacy and metabolic influenc ...... h 52 weeks follow-up in China.
@nl
P2860
P356
P1476
Efficacy and metabolic influenc ...... h 52 weeks follow-up in China.
@en
P2093
Guangzhi Dai
Yinbo Zhang
P2860
P304
P356
10.1002/HUP.2270
P577
2012-11-01T00:00:00Z